Information  X 
Enter a valid email address

Redcentric PLC (RCN)


Wednesday 20 October, 2021

Redcentric PLC

Issue of Equity

RNS Number : 5607P
Redcentric PLC
20 October 2021


Redcentric plc

("Redcentric" or the "Group")  

Exercise of Options

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, announces that following an exercise of options pursuant to the Company's 2016 Long Term Incentive Plan, it has issued and allotted 155,346 new ordinary shares in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on or around the 29 October 2021.

As a result, the Company's issued share capital now consists of 156,493,533 Ordinary Shares, 19,703 of which remain held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any Ordinary Shares held in Treasury and should use the figure of 156,473,830 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.


Redcentric plc    +44 (0)800 983 2522 

Peter Brotherton, Chief Executive Officer 

David Senior, Chief Financial Officer   

finnCap Ltd - Nomad and Broker +44 (0)20 7220 0500

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)   

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t